A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors

计划入组 25 人 · 首次发布于 2021 年 4 月 21 日

A Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid Tumors

计划入组 158 人 · 首次发布于 2023 年 2 月 14 日

Broad Effectiveness: Study With Aripiprazole

计划入组 444 人 · 首次发布于 2002 年 5 月 10 日

ELI-202

ANGPTL3 siRNA (Eli Lilly and Company)

CNS therapeutics (Eli Lilly and Company)

Eli Lilly and Company

Costa Rica

Eli Lilly and Company

United States

ELI LILLY AND COMPANY LIMITED

United Kingdom

UCLA-Led Consortium Launches Billion Cell×Cell Project to Decode Cellular Communication, Published in Nature Biotechnology

UCLA Study Reveals SSRIs May Enhance Immune Response Against Cancer

UCLA Develops Off-the-Shelf CAR-NKT Cell Therapy for Metastatic Kidney Cancer